Core Viewpoint - Abbott, a global leader in healthcare, will participate in the upcoming China International Import Expo (CIIE) for the sixth consecutive year, showcasing innovative healthcare solutions that address public health management needs [1][2] Group 1: Participation in CIIE - Abbott will present in the medical devices and healthcare section, highlighting innovations across various healthcare fields [1] - The company has showcased hundreds of innovative life sciences products at previous expos, including many that debuted in Asia or China [1] Group 2: Innovations and Technologies - Abbott will introduce several advanced technologies, including biowearable sensor technology, real-time precise data connectivity, minimally invasive treatment options, and personalized diagnostic decision-making [1] - A notable highlight is the debut of the Diamondback 360™ coronary orbital atherectomy system, which uses a diamond-coated rotating head to remove calcified plaque in coronary arteries, facilitating safer stent placement [1] Group 3: Commitment to Sustainable Development - Abbott emphasizes its commitment to sustainable development and expanding access to health solutions through its participation in CIIE [2] - The company aims to leverage the expo platform to promote high-quality development in the healthcare industry and enhance health benefits for the public [2]